Goldman Sachs Group Inc 89bio, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in 89bio, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 733,497 shares of ETNB stock, worth $5.85 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
733,497
Previous 904,817 18.93%
Holding current value
$5.85 Million
Previous $7.25 Million 25.11%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$7.36 - $9.66 $1.26 Million - $1.65 Million
-171,320 Reduced 18.93%
733,497 $5.43 Million
Q2 2024

Aug 13, 2024
BUY
$7.31 - $10.9 $1.17 Million - $1.74 Million
159,869 Added 21.46%
904,817 $7.25 Million
Q1 2024

May 15, 2024
BUY
$8.13 - $13.77 $925,486 - $1.57 Million
113,836 Added 18.04%
744,948 $8.67 Million
Q4 2023

Feb 13, 2024
BUY
$6.66 - $16.03 $748,837 - $1.8 Million
112,438 Added 21.68%
631,112 $7.05 Million
Q3 2023

May 14, 2024
SELL
$15.06 - $19.41 $1.69 Million - $2.18 Million
-112,438 Reduced 17.82%
518,674 $8.01 Million
Q3 2023

Nov 14, 2023
SELL
$15.06 - $19.41 $1.45 Million - $1.87 Million
-96,493 Reduced 15.69%
518,674 $8.01 Million
Q2 2023

May 14, 2024
BUY
$14.15 - $22.03 $2.08 Million - $3.24 Million
146,976 Added 31.39%
615,167 $11.7 Million
Q2 2023

Aug 14, 2023
BUY
$14.15 - $22.03 $2.08 Million - $3.24 Million
146,976 Added 31.39%
615,167 $11.7 Million
Q1 2023

May 14, 2024
SELL
$10.48 - $16.94 $2.01 Million - $3.25 Million
-191,733 Reduced 29.05%
468,191 $7.13 Million
Q1 2023

May 11, 2023
SELL
$10.48 - $16.94 $2.01 Million - $3.25 Million
-191,733 Reduced 29.05%
468,191 $7.13 Million
Q4 2022

May 14, 2024
BUY
$5.52 - $12.73 $1.5 Million - $3.45 Million
271,344 Added 69.83%
659,924 $8.4 Million
Q4 2022

Feb 13, 2023
BUY
$5.52 - $12.73 $1.5 Million - $3.45 Million
271,344 Added 69.83%
659,924 $8.4 Million
Q3 2022

May 14, 2024
BUY
$3.02 - $7.0 $913,607 - $2.12 Million
302,519 Added 351.52%
388,580 $2.25 Million
Q3 2022

Nov 10, 2022
BUY
$3.02 - $7.0 $913,607 - $2.12 Million
302,519 Added 351.52%
388,580 $0
Q2 2022

May 14, 2024
SELL
$2.09 - $4.02 $1.14 Million - $2.19 Million
-545,051 Reduced 86.36%
86,061 $277,000
Q2 2022

Aug 15, 2022
BUY
$2.09 - $4.02 $33,492 - $64,420
16,025 Added 22.88%
86,061 $277,000
Q1 2022

May 16, 2022
BUY
$3.45 - $14.99 $206,278 - $896,267
59,791 Added 583.61%
70,036 $264,000
Q4 2021

Feb 14, 2022
BUY
$11.15 - $19.66 $114,231 - $201,416
10,245 New
10,245 $134,000

Others Institutions Holding ETNB

# of Institutions
158
Shares Held
108M
Call Options Held
73.6K
Put Options Held
1.19M
View Full List

About 89bio, Inc.

ETNB Quotes by TradingView
  • Ticker ETNB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,484,500
  • Market Cap $371M
  • Description
  • 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...
More about ETNB
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email